Bottom line
IHE vs FHLC: the short answer
IHE (iShares U.S. Pharmaceuticals ETF) and FHLC (Fidelity MSCI Health Care Index ETF) share a meaningful slice of their top holdings — about 41% by weight.
But FHLC is far broader, holding 337 positions to 59 for IHE, so beyond the top names it adds exposure IHE doesn't have.
FHLC is cheaper at 0.084% vs 0.37% — a difference of $29 a year per $10,000 invested.
Over five years, IHE returned +9.1% a year vs +7.2% for FHLC (reporting dates differ).
Updated Nov 19, 2026
IHE vs FHLC side by side
| IHE | FHLC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.084% |
| Annual cost per $10k | $37 | $8.4 |
| 10-yr cost on $10k (prospectus) | $468 | $108 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +31.7% | +2.6% |
| 5-yr return (annualized) | +9.1% | +7.2% |
| 10-yr return (annualized) | +6.2% | +8.8% |
| Best quarter | +17.6% | +16.4% |
| Worst quarter | −16.0% | −13.1% |
| Net assets (fund) | $1.1B | $3.3B |
| Number of holdings | 59 | 337 |
| Portfolio turnover | 29% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHE | FHLC | Difference |
|---|---|---|---|
| 2024 | +8.1% | +2.6% | +5.5% |
| 2023 | +1.0% | +2.5% | −1.5% |
| 2022 | −4.8% | −5.5% | +0.7% |
| 2021 | +12.8% | +20.4% | −7.5% |
| 2020 | +13.8% | +18.1% | −4.3% |
| 2019 | +15.5% | +21.9% | −6.5% |
| 2018 | −7.7% | +5.5% | −13.2% |
| 2017 | +10.7% | +23.3% | −12.7% |
| 2016 | −11.7% | −3.3% | −8.4% |
| 2015 | +8.8% | +7.0% | +1.8% |
Source: Fund prospectus bar charts
Holdings overlap
5 of IHE's top 25 holdings also appear in FHLC's top 25.
| Holding | IHE | FHLC |
|---|---|---|
| Johnson & Johnson | 22.44% | 8.93% |
| Eli Lilly And Company | 22.25% | 13.35% |
| Merck & Co., Inc. | 4.55% | 4.66% |
| Bristol-myers Squibb Company | 4.37% | 1.93% |
| Pfizer Inc. | 3.96% | 2.06% |
Source: SEC Form N-PORT
IHE top 10
- Johnson & Johnson — 22.44%
- Eli Lilly And Company — 22.25%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Merck & Co., Inc. — 4.55%
- Bristol-myers Squibb Company — 4.37%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between IHE and FHLC?
Which is cheaper, IHE or FHLC?
Should I own both IHE and FHLC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.